Literature DB >> 20810205

PSCDGs of mouse multipotent adult germline stem cells can enter and progress through meiosis to form haploid male germ cells in vitro.

Jessica Nolte1, Hans W Michelmann, Marieke Wolf, Gerald Wulf, Karim Nayernia, Andreas Meinhardt, Ulrich Zechner, Wolfgang Engel.   

Abstract

Spermatogonial stem cells (SSCs) provide the basis for spermatogenesis throughout adult life by undergoing self-renewal and differentiation into sperm. SSC-derived cell lines called multipotent adult germline stem cells (maGSCs) were recently shown to be pluripotent and to have the same potential as embryonic stem cells (ESCs). In a differentiation protocol using retinoic acid (RA) and based on a double selection strategy, we have shown that ESCs are able to undergo meiosis and produce haploid male germ cells in vitro. Using this differentiation protocol we have now succeeded to generate haploid male germ cells from maGSCs in vitro. maGSCs derived from a Stra8-EGFP transgenic mouse line were differentiated into stable spermatogonial stages and further cultured. These cells were transfected with a postmeiotic specific promoter construct Prm1-DsRed to monitor retinoic acid (RA) induced differentiation into haploid male gametes. Our protocol is another approach for the production of pluripotent stem cell derived gametes (PSCDGs) and is an alternative for the investigation of mammalian spermatogenesis, germ line gene modification and epigenetic reprogramming. If reproducible with pluripotent cell lines derived from human SSCs, it could also be used as a therapeutic approach for the treatment of male infertility.
Copyright © 2010 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20810205     DOI: 10.1016/j.diff.2010.08.001

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  7 in total

1.  Induction of goat bone marrow mesenchymal stem cells into putative male germ cells using mRNA for STRA8, BOULE and DAZL.

Authors:  Yan-Li Zhang; Pei-Zhen Li; Jing Pang; Yong-Jie Wan; Guo-Min Zhang; Yi-Xuan Fan; Zi-Yu Wang; Nie-Hai Tao; Feng Wang
Journal:  Cytotechnology       Date:  2019-02-14       Impact factor: 2.058

2.  Direct differentiation of human pluripotent stem cells into haploid spermatogenic cells.

Authors:  Charles A Easley; Bart T Phillips; Megan M McGuire; Jennifer M Barringer; Hanna Valli; Brian P Hermann; Calvin R Simerly; Aleksander Rajkovic; Toshio Miki; Kyle E Orwig; Gerald P Schatten
Journal:  Cell Rep       Date:  2012-08-23       Impact factor: 9.423

3.  Differentiation of spermatogonial stem cell-like cells from murine testicular tissue into haploid male germ cells in vitro.

Authors:  Peng Wang; Li-Juan Suo; Hua Shang; Ying Li; Guang-Xuan Li; Qing-Wang Li; Jian-Hong Hu
Journal:  Cytotechnology       Date:  2013-06-02       Impact factor: 2.058

4.  Male fertility: Is spermiogenesis the critical step for answering biomedical issues?

Authors:  Marine Baptissart; Aurélie Vega; Emmanuelle Martinot; David H Volle
Journal:  Spermatogenesis       Date:  2013-04-01

Review 5.  Spermatogonial Stem Cell-Based Therapies: Taking Preclinical Research to the Next Level.

Authors:  Iris Sanou; Jillis van Maaren; Jitske Eliveld; Qijing Lei; Andreas Meißner; Annemieke A de Melker; Geert Hamer; Ans M M van Pelt; Callista L Mulder
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-04       Impact factor: 6.055

Review 6.  Stem cells as new agents for the treatment of infertility: current and future perspectives and challenges.

Authors:  Vladislav Volarevic; Sanja Bojic; Jasmin Nurkovic; Ana Volarevic; Biljana Ljujic; Nebojsa Arsenijevic; Majlinda Lako; Miodrag Stojkovic
Journal:  Biomed Res Int       Date:  2014-04-14       Impact factor: 3.411

7.  Meiotic Chromosome Synapsis and XY-Body Formation In Vitro.

Authors:  Qijing Lei; Eden Zhang; Ans M M van Pelt; Geert Hamer
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-14       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.